… quadrivalent HPV vaccine were effective against genital warts in our population. Moreover,
with low vaccine coverage the incidence of genital warts decreased only in the vaccinated. …

… HPV vaccine. In an effectiveness study covering the entire Swedish population, HPV vaccine
effectiveness against genital warts … <14 years) and vaccine effectiveness decreased with …

… HPV vaccine, the question now is whether the vaccine is in fact … Gardasil ® the question of
which clinical endpoint should be monitored, was addressed. Clearly the most significant HPV-…

… Genital warts caused by HPV 6 and 11 have a lifetime risk of acquisition of 10%. HPV vaccines
are subunit vaccines … Two vaccines have been licenced since 2006/2007 and are in the …

… To assess the effectiveness of the HPV vaccines in preventing genital warts (GW) in women
aged 14–23 years and to estimate the incidence of GW in the whole population aged from …

… that the incidence of GWs in women increased until initiation of HPV vaccination. In 2007, the
… women and particularly those 17 years and younger, the group to whom HPV vaccination …

… quadrivalent vaccine as a public health program against HPV … young men and young women,
although more commonly … an HPV vaccine trial's placebo group, which included women …

… Types 6 and 11 do not contribute to the incidence of high-grade dysplasias (precancerous
lesions) or cervical cancer, but do cause laryngeal papillomas and most genital warts. …

… human papillomavirus (HPV) vaccine has been assumed to give protection against genital
warts (… Our main question was whether HPV vaccine has any effects on the prevention of GW …

… the burden of HPV, the risk factors for HPV infection, genital warts and cervical … genital wart
lesions found in over 8000 women who were participants in the placebo-arms of HPV vaccine …